19.75
-0.42
(-2.08%)
At close: 3:00:05 PM GMT+8
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 1.62B | 2.03B |
| Low Estimate | -- | -- | 1.6B | 2.02B |
| High Estimate | -- | -- | 1.64B | 2.04B |
| Year Ago Sales | -- | -- | 1.26B | 1.62B |
| Sales Growth (year/est) | -- | -- | 28.39% | 25.33% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 605116.SS | -- | -- | -- | -- |
| S&P 500 | 13.90% | 7.87% | 13.12% | 14.10% |
Related Tickers
HQ1.MU Oruka Therapeutics Inc. R
11.20
+3.70%
6Y4.F Vicore Pharma Holding AB (publ)
0.7310
-2.14%
8F8.SG SynAct Pharma AB
1.3460
-1.68%
REGN.MX Regeneron Pharmaceuticals, Inc.
13,757.24
+0.80%
ICY.SG Incyte Corp
66.72
+1.15%
22UA.DU BioNTech SE
112.70
+4.35%
PH4.F CStone Pharmaceuticals
0.3060
-2.55%
ALGEN.PA genOway Société anonyme
3.5400
+2.31%
0WA2.IL Cellectis S.A.
1.5200
0.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3310
+0.61%